Skip to content

TaskUs TASK Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$1.21B+15.9%$1.18B+19.0%$1.14B+19.9%$1.1B+19.0%$1.05B+14.1%
$762.97M+19.5%$736.36M+22.1%$707.02M+24.0%$675.36M+23.5%$638.67M+19.1%
$449.05M+10.4%$447.19M+14.1%$437.82M+13.8%$426.11M+12.6%$406.64M+7.0%
37%-1.9pp37.8%-1.6pp38.2%-2.0pp38.7%-2.2pp38.9%-2.6pp
$245.75M+0.7%$244.89M+2.2%$253.28M+14.7%$256.24M+19.0%$244.11M+12.4%
$1.07B+13.7%$1.04B+15.6%$1.02B+19.6%$990.72M+20.2%$942.2M+15.4%
$140.6M+36.4%$140.63M+52.2%$124.49M+22.1%$110.74M+9.9%$103.1M+2.9%
11.6%+1.7pp11.9%+2.6pp10.9%+0.2pp10.1%-0.8pp9.9%-1.1pp
$18.99M-8.1%$18.39M-14.7%$18.94M-14.3%$19.82M-11.2%$20.67M-6.7%
$21.59M+559%$14.43M+337%$11.21M+199%$1.9M+8.3%$3.28M+1,341%
$143.19M+67.1%$136.67M+84.2%$116.76M+39.6%$92.83M+15.8%$85.71M+10.2%
$37.73M+24.1%$34.4M+21.5%$35.33M+16.4%$30.07M+0.8%$30.4M+1.7%
$105.46M+90.7%$102.28M+123%$81.43M+52.8%$62.75M+24.6%$55.3M+15.5%
8.7%+3.4pp8.6%+4.0pp7.1%+1.5pp5.7%+0.3pp5.3%+0.1pp
$1.14+86.9%$1.11+118%$0.89+50.8%$0.69+25.5%$0.61+19.6%
$203.19M+25.1%$202.14M+32.5%$184.8M+13.1%$170.01M+4.8%$162.47M+0.3%
16.8%+1.2pp17.1%+1.7pp16.1%-1.0pp15.4%-2.1pp15.5%-2.1pp
$140.6M+36.4%$140.63M+52.2%$124.49M+22.1%$110.74M+9.9%$103.1M+2.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is TaskUs's revenue?
TaskUs (TASK) generated $1.2B in revenue over the trailing twelve months, up 16.0% year over year.
Is TaskUs profitable?
TaskUs reported $105.5M in net income over the trailing twelve months, a 8.7% net margin.
What are TaskUs's profit margins?
Gross margin is 37.0% and operating margin is 11.6%, with a 8.7% net margin.
What is TaskUs's earnings per share?
TaskUs's diluted EPS over the trailing twelve months is $1.14.
Where does TaskUs's income statement data come from?
Every line is extracted from TaskUs's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.